Vito Lorusso
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial(2013)646 cited
- → Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study(2017)416 cited
- → A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy(2014)244 cited
- → Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers(1999)202 cited
- → Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study(2001)168 cited
- → Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX(2016)98 cited
- → Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue(2016)94 cited
- → Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma(2005)91 cited
- → Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome(2020)90 cited
- → Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial(2001)86 cited